Hemarina is a biotechnology company with a strong R&D activity. Our teams have a unique know-how, based on fifteen years of fundamental research. The results of our research are the subject of numerous scientific articles published in leading journals.
Characterization of a hyaluronic acid-based hydrogel containing an extracellularoxygen carrier (M101) for periodontitis treatment: an in vitro study
Int J Pharm. - 2021
Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas.
Journal of Cellular and Molecular Medicine. - 2019
Efficacy of the natural oxygen transporter HEMO2life® in cold preservation in a preclinical porcine model of donation after cardiac death.
Transplant International, official journal of the European Society for Organ Transplantation. - 2019
Preventing acute kidney injury during transplantation: the application of novel oxygen carriers.
Expert Opinion on Investigational Drugs, 28(7):643-657. - 2019